Jane Gosden

1.4k total citations · 1 hit paper
29 papers, 1.0k citations indexed

About

Jane Gosden is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Jane Gosden has authored 29 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cellular and Molecular Neuroscience, 11 papers in Pharmacology and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Jane Gosden's work include Neurotransmitter Receptor Influence on Behavior (13 papers), Attention Deficit Hyperactivity Disorder (7 papers) and Pharmacology and Obesity Treatment (7 papers). Jane Gosden is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (13 papers), Attention Deficit Hyperactivity Disorder (7 papers) and Pharmacology and Obesity Treatment (7 papers). Jane Gosden collaborates with scholars based in United Kingdom and United States. Jane Gosden's co-authors include David J. Heal, Sharon L. Smith, David Nutt, Graham P. Luscombe, David P. Hackett, Helen L. Rowley, Keith F. Martin, W. R. Buckett, Sharon C. Cheetham and M.R. Prow and has published in prestigious journals such as British Journal of Pharmacology, International Journal of Obesity and Psychopharmacology.

In The Last Decade

Jane Gosden

25 papers receiving 939 citations

Hit Papers

Amphetamine, past and present – a pharmacological and cli... 2013 2026 2017 2021 2013 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Amphetamine, past and present – a pharmacological and clinical perspective
    2013 385 citations David J. Heal, Sharon L. Smith et al. Journal of Psychopharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jane Gosden United Kingdom 15 460 256 227 209 188 29 1.0k
Jillian H. Broadbear Australia 22 526 1.1× 197 0.8× 103 0.5× 307 1.5× 305 1.6× 86 1.4k
Esa Meririnne Finland 14 392 0.9× 171 0.7× 121 0.5× 123 0.6× 314 1.7× 23 1.2k
Susan M. Learned United States 15 259 0.6× 255 1.0× 219 1.0× 77 0.4× 175 0.9× 22 1.1k
Barbara R. Haight United States 10 217 0.5× 483 1.9× 412 1.8× 152 0.7× 150 0.8× 12 1.2k
DJ Nutt United Kingdom 15 357 0.8× 147 0.6× 140 0.6× 432 2.1× 116 0.6× 35 1.2k
Jibran Y. Khokhar Canada 16 315 0.7× 231 0.9× 282 1.2× 124 0.6× 185 1.0× 75 1.1k
Oliver G. Bosch Switzerland 19 379 0.8× 168 0.7× 104 0.5× 431 2.1× 146 0.8× 36 1.3k
J.A.S. Crippa Brazil 19 548 1.2× 930 3.6× 293 1.3× 278 1.3× 162 0.9× 31 1.6k
B LEONARD Ireland 17 389 0.8× 178 0.7× 135 0.6× 102 0.5× 233 1.2× 19 1.3k
Aino Kankaanpää Finland 18 611 1.3× 193 0.8× 73 0.3× 138 0.7× 290 1.5× 32 1.3k

Countries citing papers authored by Jane Gosden

Since Specialization
Citations

This map shows the geographic impact of Jane Gosden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Gosden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Gosden more than expected).

Fields of papers citing papers by Jane Gosden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Gosden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Gosden. The network helps show where Jane Gosden may publish in the future.

Co-authorship network of co-authors of Jane Gosden

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Gosden. A scholar is included among the top collaborators of Jane Gosden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Gosden. Jane Gosden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heal, David J., Sharon L. Smith, Jane Gosden, et al.. (2025). Evaluation of the Abuse Potential of the Cholesterol-24-Hydroxylase Inhibitor, Soticlestat, in Drug-Discrimination and Self-Administration Tests. Drug and Alcohol Dependence. 267. 111937–111937.
2.
Heal, David J., Sharon L. Smith, Jane Gosden, et al.. (2025). Assessment of Withdrawal-Induced Physical Dependence in Rats After Administration of the Potent Cholesterol-24-Hydroxylase Inhibitor, Soticlestat. Drug and Alcohol Dependence. 267. 111939–111939.
3.
Heal, David J., Jane Gosden, Sharon L. Smith, & C.K. Atterwill. (2022). Experimental strategies to discover and develop the next generation of psychedelics and entactogens as medicines. Neuropharmacology. 225. 109375–109375. 13 indexed citations
4.
Heal, David J., Jane Gosden, & Sharon L. Smith. (2022). New Drugs to Treat ADHD: Opportunities and Challenges in Research and Development. Current topics in behavioral neurosciences. 57. 79–126. 10 indexed citations
5.
Heal, David J. & Jane Gosden. (2022). What pharmacological interventions are effective in binge-eating disorder? Insights from a critical evaluation of the evidence from clinical trials. International Journal of Obesity. 46(4). 677–695. 13 indexed citations
6.
Heal, David J., Jane Gosden, & Sharon L. Smith. (2018). Evaluating the abuse potential of psychedelic drugs as part of the safety pharmacology assessment for medical use in humans. Neuropharmacology. 142. 89–115. 39 indexed citations
7.
Heal, David J., Jane Gosden, Sharon C. Cheetham, et al.. (2017). Dopamine and μ-opioid receptor dysregulation in the brains of binge-eating female rats – possible relevance in the psychopathology and treatment of binge-eating disorder. Journal of Psychopharmacology. 31(6). 770–783. 21 indexed citations
8.
Heal, David J., Jane Gosden, & Sharon L. Smith. (2014). Dopamine reuptake transporter (DAT) “inverse agonism” – A novel hypothesis to explain the enigmatic pharmacology of cocaine. Neuropharmacology. 87. 19–40. 37 indexed citations
9.
10.
Heal, David J., Jane Gosden, Helen C. Jackson, Sharon C. Cheetham, & Sharon L. Smith. (2012). Metabolic Consequences of Antipsychotic Therapy: Preclinical and Clinical Perspectives on Diabetes, Diabetic Ketoacidosis, and Obesity. Handbook of experimental pharmacology. 135–164. 18 indexed citations
11.
12.
Heal, David J., Jane Gosden, & Sharon L. Smith. (2012). A review of late-stage CNS drug candidates for the treatment of obesity. International Journal of Obesity. 37(1). 107–117. 17 indexed citations
13.
Heal, David J., Jane Gosden, & Sharon L. Smith. (2012). What is the prognosis for new centrally-acting anti-obesity drugs?. Neuropharmacology. 63(1). 132–146. 48 indexed citations
14.
Heal, David J., Jane Gosden, & Sharon L. Smith. (2011). The 5-HT6 Receptor as a Target for Developing Novel Antiobesity Drugs. International review of neurobiology. 96. 73–109. 25 indexed citations
15.
Heal, David J., Jane Gosden, & Sharon L. Smith. (2009). Regulatory challenges for new drugs to treat obesity and comorbid metabolic disorders. British Journal of Clinical Pharmacology. 68(6). 861–874. 65 indexed citations
16.
Gosden, Jane & D.J. Heal. (1998). Evaluation of sibutramine, its active metabolites and dexfenfluramine in the MDMA-cued drug discrimination test. 3. 122. 2 indexed citations
17.
Heal, David J., et al.. (1995). Receptor binding and functional evidence suggest that postsynaptic α2-adrenoceptors in rat brain are of the α2D subtype. European Journal of Pharmacology. 277(2-3). 215–221. 16 indexed citations
18.
Luscombe, Graham P., et al.. (1993). Mediation of the antidepressant‐like effect of 8‐OH‐DPAT in mice by postsynaptic 5‐HT1A receptors. British Journal of Pharmacology. 108(3). 669–677. 73 indexed citations
19.
Heal, David J., et al.. (1992). A comparison of various antidepressant drugs demonstrates rapid desensitisation of α2-adrenoceptors exclusively by sibutramine hydrochloride. Psychopharmacology. 107(4). 497–502. 11 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jillian H. Broadbear Breakdown of academic impact, for papers by Esa Meririnne Breakdown of academic impact, for papers by Susan M. Learned Breakdown of academic impact, for papers by Barbara R. Haight Breakdown of academic impact, for papers by DJ Nutt Breakdown of academic impact, for papers by Jibran Y. Khokhar Breakdown of academic impact, for papers by Oliver G. Bosch Breakdown of academic impact, for papers by J.A.S. Crippa Breakdown of academic impact, for papers by B LEONARD Breakdown of academic impact, for papers by Aino Kankaanpää
Rankless by CCL
2026